These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics. Correll CU; Kratochvil CJ; March JS J Clin Psychiatry; 2011 May; 72(5):655-70. PubMed ID: 21658348 [TBL] [Abstract][Full Text] [Related]
27. When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them? Schaller JL; Behar D; Chamberlain T J Neuropsychiatry Clin Neurosci; 1998; 10(1):111-3. PubMed ID: 9547477 [No Abstract] [Full Text] [Related]
28. Attention-deficit hyperactivity disorder and brain-derived neurotrophic factor: a speculative hypothesis. Tsai SJ Med Hypotheses; 2003 Jun; 60(6):849-51. PubMed ID: 12699711 [TBL] [Abstract][Full Text] [Related]
29. Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder. Coric V; Milanovic S; Wasylink S; Patel P; Malison R; Krystal JH Psychopharmacology (Berl); 2003 May; 167(2):219-20. PubMed ID: 12658528 [No Abstract] [Full Text] [Related]
30. Clomipramine side effects. Cruz R J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1168-9. PubMed ID: 1429426 [No Abstract] [Full Text] [Related]
31. Intractable obsessive-compulsive disorder: comorbidity with unrecognized adult attention-deficit hyperactivity disorder? van der Feltz-Cornelis CM J Nerv Ment Dis; 1999 Apr; 187(4):243-5. PubMed ID: 10221558 [No Abstract] [Full Text] [Related]
32. Depression, anxiety and obsessive-compulsive symptoms and quality of life in children with attention-deficit hyperactivity disorder (ADHD) during three-month methylphenidate treatment. Gürkan K; Bilgiç A; Türkoglu S; Kiliç BG; Aysev A; Uslu R J Psychopharmacol; 2010 Dec; 24(12):1810-8. PubMed ID: 19939861 [TBL] [Abstract][Full Text] [Related]
33. [Tricyclic antidepressive agents in compulsive neuroses]. Lingjaerde O Tidsskr Nor Laegeforen; 1968 Jun; 88(11):1040-2. PubMed ID: 5685764 [No Abstract] [Full Text] [Related]
34. Coexisting major depression and obsessive-compulsive disorder treated with venlafaxine. Zajecka JM; Fawcett J; Guy C J Clin Psychopharmacol; 1990 Apr; 10(2):152-3. PubMed ID: 2341595 [No Abstract] [Full Text] [Related]
36. [The role of drugs in the treatment of obsessive-compulsive disorders]. den Boer JA; Westenberg HG Ned Tijdschr Geneeskd; 1990 Mar; 134(10):503-4. PubMed ID: 2107405 [No Abstract] [Full Text] [Related]
37. [Pharmacological treatment of attention-deficit/hyperactivity disorder in adults]. Rollini M; Baud P Rev Med Suisse; 2008 Jul; 4(165):1638-43. PubMed ID: 18767289 [TBL] [Abstract][Full Text] [Related]
38. Pediatric clonidine poisoning as a result of pharmacy compounding error. Suchard JR; Graeme KA Pediatr Emerg Care; 2002 Aug; 18(4):295-6. PubMed ID: 12187137 [No Abstract] [Full Text] [Related]